Skip to content

Clinical trials

Phase 4 Parkinson Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 4 Country / region: United States Clear all

72 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20041
20052
20064
20079
20081
20097
20104
20114
20127
20131
20142
20151
20165
20173
20181
20194
20202
20211
20233
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed49
Terminated7
Recruiting6
Not yet recruiting3
Unknown status3
Withdrawn2
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Baylor College of Medicine4
University of South Florida4
Boehringer Ingelheim3
Oregon Health and Science University3
University of Pennsylvania3
Emory University2
Georgetown University2
GlaxoSmithKline2
MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals2
Stanford University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease72
Cognitive Dysfunction4
Urinary Bladder, Overactive4
Dementia3
Dyskinesias3
Parkinsonian Disorders3
Urinary Incontinence3
Fatigue2
Lewy Body Disease2
Multiple System Atrophy2

Trials

Showing 1 to 25 of 72. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.